Clinical Trial

A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-07-24; most recent amendment 2025-11-12.
Status change: Not Yet Recruiting → Recruiting 2024-09-23
Trial Details
NCT Number NCT06525636
Lead Sponsor Kyowa Kirin Co., Ltd.
Collaborators: Kyowa Kirin, Inc.
Conditions X-linked Hypophosphatemia
Enrollment 24 participants
Start Date 2024-10-09
Primary Completion 2028-02-11 (estimated)
Study Completion 2028-05-10 (estimated)
Updated on ClinicalTrials.gov 2025-11-14